Skip to content
value.today

HemoSonics, LLC

Total raised
$25 M
5 rounds on record
Latest round
$15 M
Jan 2017
First round on record
Nov 2008
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of HemoSonics, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2017$15 MNo. 5$10 to $50 million

HemoSonics, LLC: Raise no. 5, Jan 2017

Investors in this round

1 investor had bought by the notice of Feb 14, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,058,685
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Virginia

People named in the notice

  • Francesco F. Viola · Executive Officer, Director · Manager
  • Timothy Fischer · Executive Officer, Director · Manager
  • Antoine P. Coulot · Director · Manager
  • Josep P. Manent · Director · Manager
  • Mark F. Wheeler · Director · Manager
  • Philippe P. Barroux · Director · Manager
  • William F. Walker · Director · Manager
  • William P. Moffitt · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ferghana Securities Inc. (CRD 43430) · broker-dealer E. Hunterson Henrie, II (CRD 2431896) · New York, New YorkSold in no state named, and outside the US

Remarks in the notice

  • On fees: “Represents total commissions paid in combination of cash and warrants.”
  • On the use of proceeds: “Proceeds are used for general working capital, which may include normal compensation to executive officers/managers.”

Signed by Timothy J. Fischer, President and CEO. Source: SEC Form D, newest notice filed Feb 14, 2017. Read the notice at the SEC.

equitySEC
Nov 2015$4 MNo. 4$2 to $10 million

HemoSonics, LLC: Raise no. 4, Nov 2015

Investors in this round

34 investors had bought by the notice of Aug 19, 2016: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $8 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Virginia

People named in the notice

  • Timothy J. Fischer · Executive Officer, Director · Manager
  • Francesco F. Viola · Director · Manager
  • Josep P Manent · Director · Manager
  • Mark F. Wheeler · Director
  • William F. Walker · Director · Manager
  • William P Moffitt · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds are used for general working capital, which may include normal compensation to executed officers/managers.”

Signed by Timothy J. Fischer, President and CEO. Source: SEC Form D, newest notice filed Aug 19, 2016. Read the notice at the SEC.

equity, optionsSEC
Jul 2014$4 MNo. 3$2 to $10 million

HemoSonics, LLC: Raise no. 3, Jul 2014

Investors in this round

29 investors had bought by the notice of Aug 19, 2016: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $6 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Virginia

People named in the notice

  • Francesco F. Viola · Executive Officer, Director · Manager
  • Timothy J. Fischer · Executive Officer, Director · Manager
  • Josep P. Manent · Director · Manager
  • Mark F. Wheeler · Director · Manager
  • William F. Walker · Director · Manager
  • William P. Moffitt · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds are used for general working capital, which may include normal compensation to executive officers/managers.”

Signed by Timothy J. Fischer, President and CEO. Source: SEC Form D, newest notice filed Aug 19, 2016. Read the notice at the SEC.

equitySEC
Jan 2013$1 MNo. 2Under $2 million

HemoSonics, LLC: Raise no. 2, Jan 2013

Investors in this round

9 investors had bought by the notice of Jun 11, 2013: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Francesco Viola · Executive Officer, Director
  • David Freed · Director
  • Jonathan Sackier · Director
  • Mark Wheeler · Director
  • Matt Hantzmon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William F. Walker, Manager and President. Source: SEC Form D, newest notice filed Jun 11, 2013. Read the notice at the SEC.

equitySEC
Nov 2008$1 MNo. 1Under $2 million

HemoSonics, LLC: Raise no. 1, Nov 2008

Investors in this round

7 investors had bought by the notice of Jun 28, 2010: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Francesco F Viola · Executive Officer
  • Michael B Laurence · Executive Officer
  • William F Walker · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William F. Walker, Manager and President. Source: SEC Form D, newest notice filed Jun 28, 2010. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • HemoSonics, LLC chose not to state its revenue in its newest notice of a funding round (Feb 2017).

    SEC Form D · Feb 2017

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2017

That is all the official record says: HemoSonics, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of HemoSonics, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 34 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by HemoSonics, LLC
NameRoleNamed in
Francesco F. ViolaManagerFeb 2017
Timothy FischerManagerFeb 2017
Timothy J. FischerManagerAug 2016
Francesco ViolaExecutive officerJun 2013
Francesco F ViolaExecutive officerJun 2010
Michael B LaurenceExecutive officerJun 2010
William F WalkerExecutive officerJun 2010
Antoine P. CoulotManagerFeb 2017
Francesco F. ViolaManagerFeb 2017
Josep P. ManentManagerFeb 2017
Mark F. WheelerManagerFeb 2017
Philippe P. BarrouxManagerFeb 2017
Timothy FischerManagerFeb 2017
William F. WalkerManagerFeb 2017
William P. MoffittManagerFeb 2017
Josep P ManentManagerAug 2016
Timothy J. FischerManagerAug 2016
William P MoffittManagerAug 2016
David FreedDirectorJun 2013
Francesco ViolaDirectorJun 2013
Jonathan SackierDirectorJun 2013
Mark WheelerDirectorJun 2013
Matt HantzmonDirectorJun 2013
William F WalkerDirectorJun 2010